The tobacco carcinogen NNK is stereoselectively reduced by human pancreatic microsomes and cytosols

Langenbeck's Archives of Surgery

Volumn 393, Issue 4, 2008, Pages 571-579

  Trushin, Neil ^a   Leder, Gerhard ^b   El Bayoumy, Karam ^c   Hoffmann, Dietrich ^d   Beger, Hans G ^e   Henne Bruns, Doris ^b   Ramadani, Marco ^b   Prokopczyk, Bogdan ^c  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF ULM   (Germany)

^c PENN STATE CANCER INSTITUTE   (United States)

^d AMERICAN HEALTH FOUNDATION   (United States)

^e Donauklinik   (Germany)

Author keywords

NNAL; NNK; Pancreatic cancer; Smoking

Indexed keywords

4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANOL; CARCINOGEN; NITROSAMINE 4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANONE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOSOL; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; ISOMER; LIVER METABOLISM; MALE; METABOLITE; MICROSOME; MOUSE; NONHUMAN; PANCREAS; PANCREAS JUICE; PRIORITY JOURNAL; STEREOCHEMISTRY;

EID: 43149105979     PISSN: 14352443     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00423-007-0265-3     Document Type: Article

References (31)

1. 1. A Jemal R Siegel E Ward T Murray J Xu C Smigal MJ Thun 2006 Cancer statistics, 2006 CA Cancer J Clin 56 106 130 16514137 10.3322/canjclin.56.2.106 Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, Thun MJ (2006) Cancer statistics, 2006. CA Cancer J Clin 56:106–130
2. 2. L Gallicchio A Kouzis JM Genkinger AE Burke SC Hoffman M Diener-West KJ Helzlsouer GW Comstock AJ Alberg 2006 Active cigarette smoking, household passive smoke exposure, and the risk of developing pancreatic cancer Prev Med 42 200 205 16458957 10.1016/j.ypmed.2005.12.014 Gallicchio L, Kouzis A, Genkinger JM, Burke AE, Hoffman SC, Diener-West M, Helzlsouer KJ, Comstock GW, Alberg AJ (2006) Active cigarette smoking, household passive smoke exposure, and the risk of developing pancreatic cancer. Prev Med 42:200–205
3. 3. M Shen P Boffetta JH Olsen A Andersen K Hemminki E Pukkala E Tracey DH Brewster ML McBride V Pompe-Kirn EV Kliewer JM Tonita KS Chia C Martos JG Jonasson D Colin G Scelo P Brennan 2006 A pooled analysis of second primary pancreatic cancer Am J Epidemiol 163 502 511 16421239 10.1093/aje/kwj073 Shen M, Boffetta P, Olsen JH, Andersen A, Hemminki K, Pukkala E, Tracey E, Brewster DH, McBride ML, Pompe-Kirn V, Kliewer EV, Tonita JM, Chia KS, Martos C, Jonasson JG, Colin D, Scelo G, Brennan P (2006) A pooled analysis of second primary pancreatic cancer. Am J Epidemiol 163:502–511
4. 4. BCH Chiu CF Lynch JR Cerhan KP Cantor 2001 Cigarette smoking and risk of bladder, pancreas, kidney, and colorectal cancers in Iowa Ann Epidemiol 11 28 37 11164117 10.1016/S1047-2797(00)00175-7 1:STN:280:DC%2BD3M7ksF2jtw%3D%3D Chiu BCH, Lynch CF, Cerhan JR, Cantor KP (2001) Cigarette smoking and risk of bladder, pancreas, kidney, and colorectal cancers in Iowa. Ann Epidemiol 11:28–37
5. 5. SS Coughlin EE Calle AV Patel MJ Thun 2000 Predictors of pancreatic cancer mortality among a large cohort of United States adults Cancer Causes Control 11 915 923 11142526 10.1023/A:1026580131793 1:STN:280:DC%2BD3M7jvVSjuw%3D%3D Coughlin SS, Calle EE, Patel AV, Thun MJ (2000) Predictors of pancreatic cancer mortality among a large cohort of United States adults. Cancer Causes Control 11:915–923
6. 6. EL Wynder K Mabuchi N Maruchi JG Fortner 1973 A case control study of cancer of the pancreas Cancer 31 641 648 4693593 10.1002/1097-0142(197303)31:3<641::AID-CNCR2820310323>3.0.CO;2-1 1:STN:280:DyaE3s7ksFGrsg%3D%3D Wynder EL, Mabuchi K, Maruchi N, Fortner JG (1973) A case control study of cancer of the pancreas. Cancer 31:641–648
7. 7. JE Muscat SD Stellman D Hoffmann EL Wynder 1997 Smoking and pancreatic cancer in men and women Cancer Epidemiol Biomark Prev 6 15 19 1:STN:280:DyaK2s7ks12gtA%3D%3D Muscat JE, Stellman SD, Hoffmann D, Wynder EL (1997) Smoking and pancreatic cancer in men and women. Cancer Epidemiol Biomark Prev 6:15–19
8. 8. P Ghadirian A Simard J Baillargeon 1991 Tobacco, alcohol, and coffee and cancer of the pancreas. A population-based, case control study in Quebec, Canada Cancer 67 2664 2670 2015568 10.1002/1097-0142(19910515)67:10<2664::AID-CNCR2820671043>3.0.CO;2-K 1:STN:280:DyaK3M7pvFSnsg%3D%3D Ghadirian P, Simard A, Baillargeon J (1991) Tobacco, alcohol, and coffee and cancer of the pancreas. A population-based, case control study in Quebec, Canada. Cancer 67:2664–2670
9. 9. HA Kahn 1966 The Dorn study of smoking and mortality among U.S. veterans: report on eight and one-half years of observation Natl Cancer Inst Monogr 19 1 125 5905668 1:STN:280:DyaF28%2FpsFCkuw%3D%3D Kahn HA (1966) The Dorn study of smoking and mortality among U.S. veterans: report on eight and one-half years of observation. Natl Cancer Inst Monogr 19:1–125
10. 10. D Hoffmann I Hoffmann K El-Bayoumy 2001 The less harmful cigarette: a controversial issue. A tribute to Ernst L. Wynder Chem Res Toxicol 14 767 790 11453723 10.1021/tx000260u 1:CAS:528:DC%2BD3MXks1ekt7o%3D Hoffmann D, Hoffmann I, El-Bayoumy K (2001) The less harmful cigarette: a controversial issue. A tribute to Ernst L. Wynder. Chem Res Toxicol 14:767–790
11. 11. SS Hecht 1998 Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines Chem Res Toxicol 11 559 603 9625726 10.1021/tx980005y 1:CAS:528:DyaK1cXjvFarsrs%3D Hecht SS (1998) Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines. Chem Res Toxicol 11:559–603
12. 12. D Hoffmann A Rivenson R Abbi EL Wynder 1993 A study of tobacco carcinogenesis: effect of the fat content of the diet on the carcinogenic activity of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in F344 rats Cancer Res 53 2758 2761 8389244 1:CAS:528:DyaK3sXltFWjs7g%3D Hoffmann D, Rivenson A, Abbi R, Wynder EL (1993) A study of tobacco carcinogenesis: effect of the fat content of the diet on the carcinogenic activity of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in F344 rats. Cancer Res 53:2758–2761
13. 13. A Rivenson D Hoffmann B Prokopczyk S Amin SS Hecht 1988 Induction of lung and exocrine pancreas tumors in F344 rats by tobacco-specific and Areca-derived N-nitrosamines Cancer Res 48 6912 6917 3180100 1:CAS:528:DyaL1MXlt1Kqsg%3D%3D Rivenson A, Hoffmann D, Prokopczyk B, Amin S, Hecht SS (1988) Induction of lung and exocrine pancreas tumors in F344 rats by tobacco-specific and Areca-derived N-nitrosamines. Cancer Res 48:6912–6917
14. 14. H Ouyang L-j Mou C Luk N Liu J Karaskova J Squire M-S Tsao 2000 Immortal human pancreatic duct epithelial cell lines with near normal genotype and phenotype Am J Pathol 157 1623 1631 11073822 1:CAS:528:DC%2BD3cXosFyhs7o%3D Ouyang H, Mou L-j, Luk C, Liu N, Karaskova J, Squire J, Tsao M-S (2000) Immortal human pancreatic duct epithelial cell lines with near normal genotype and phenotype. Am J Pathol 157:1623–1631
15. 15. B Prokopczyk D Hoffmann M Bologna AJ Cunningham N Trushin S Akerkar T Boyiri S Amin D Desai S Colosimo B Pittman G Leder M Ramadani D Henne-Bruns HG Beger K El-Bayoumy 2002 Identification of tobacco-derived compounds in human pancreatic juice Chem Res Toxicol 15 677 685 12018989 10.1021/tx0101088 1:CAS:528:DC%2BD38Xjt12qsbg%3D Prokopczyk B, Hoffmann D, Bologna M, Cunningham AJ, Trushin N, Akerkar S, Boyiri T, Amin S, Desai D, Colosimo S, Pittman B, Leder G, Ramadani M, Henne-Bruns D, Beger HG, El-Bayoumy K (2002) Identification of tobacco-derived compounds in human pancreatic juice. Chem Res Toxicol 15:677–685
16. 16. SS Hecht SG Carmella SE Murphy S Akerkar K Brunnemann D Hoffmann 1993 A tobacco-specific lung carcinogen in the urine of men exposed to cigarette smoke N Engl J Med 329 1543 1546 8413477 10.1056/NEJM199311183292105 1:CAS:528:DyaK2cXmtFagsQ%3D%3D Hecht SS, Carmella SG, Murphy SE, Akerkar S, Brunnemann K, Hoffmann D (1993) A tobacco-specific lung carcinogen in the urine of men exposed to cigarette smoke. N Engl J Med 329:1543–1546
17. 17. SG Carmella SA Akerkar JP Richie SS Hecht 1995 Intraindividual and interindividual differences in metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in smokers’ urine Cancer Epidemiol Biomark Prev 4 635 642 1:CAS:528:DyaK2MXoslKitrg%3D Carmella SG, Akerkar SA, Richie JP, Hecht SS (1995) Intraindividual and interindividual differences in metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in smokers’ urine. Cancer Epidemiol Biomark Prev 4:635–642
18. 18. P Upadhyaya PMJ Kenney JB Hochalter M Wang SS Hecht 1999 Tumorigenicity and metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol enantiomers and metabolites in the A/J mouse Carcinogenesis 20 1577 1582 10426810 10.1093/carcin/20.8.1577 1:CAS:528:DyaK1MXltlKnsrw%3D Upadhyaya P, Kenney PMJ, Hochalter JB, Wang M, Hecht SS (1999) Tumorigenicity and metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol enantiomers and metabolites in the A/J mouse. Carcinogenesis 20:1577–1582
19. 19. ME Staretz SE Murphy CJ Patten MG Nunes W Koehl S Amin LA Koenig FP Guengerich SS Hecht 1997 Comparative metabolism of the tobacco-related carcinogens benzo[a]pyrene, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol and N ′-nitrosonornicotine in human hepatic microsomes Drug Metab Dispos 25 154 162 9029045 1:CAS:528:DyaK2sXhs1GntLw%3D Staretz ME, Murphy SE, Patten CJ, Nunes MG, Koehl W, Amin S, Koenig LA, Guengerich FP, Hecht SS (1997) Comparative metabolism of the tobacco-related carcinogens benzo[a]pyrene, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol and N ′-nitrosonornicotine in human hepatic microsomes. Drug Metab Dispos 25:154–162
20. 20. CB Chen SS Hecht D Hoffmann 1978 Metabolic α-hydroxylation of the tobacco-specific carcinogen, N ′-nitrosonornicotine Cancer Res 38 3639 3645 359127 1:CAS:528:DyaE1MXkvFehsw%3D%3D Chen CB, Hecht SS, Hoffmann D (1978) Metabolic α-hydroxylation of the tobacco-specific carcinogen, N ′-nitrosonornicotine. Cancer Res 38:3639–3645
21. 21. H McKennis SL Schwartz LB Turnbull E Tamaki ER Bowman 1964 Metabolic formation of gamma-(3-pyridyl)-gamma-hydroxybutyric acid and its possible intermediary role in mammalian metabolism of nicotine J Biol Chem 239 3981 3989 14260867 1:CAS:528:DyaF2cXkvVKkur8%3D McKennis H, Schwartz SL, Turnbull LB, Tamaki E, Bowman ER (1964) Metabolic formation of gamma-(3-pyridyl)-gamma-hydroxybutyric acid and its possible intermediary role in mammalian metabolism of nicotine. J Biol Chem 239:3981–3989
22. 22. B Prokopczyk N Trushin J Leszczynska SE Waggoner K El-Bayoumy 2001 Human cervical tissue metabolizes the tobacco-specific nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, via α-hydroxylation and carbonyl reduction pathways Carcinogenesis 22 107 114 11159748 10.1093/carcin/22.1.107 1:CAS:528:DC%2BD3MXptVekuw%3D%3D Prokopczyk B, Trushin N, Leszczynska J, Waggoner SE, El-Bayoumy K (2001) Human cervical tissue metabolizes the tobacco-specific nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, via α-hydroxylation and carbonyl reduction pathways. Carcinogenesis 22:107–114
23. 23. TJ Smith GD Stoner CS Yang 1995 Activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in human lung microsomes by cytochromes P450, lipoxygenase, and hydroperoxides Cancer Res 55 5566 5573 7585636 1:CAS:528:DyaK2MXps1KrtLc%3D Smith TJ, Stoner GD, Yang CS (1995) Activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in human lung microsomes by cytochromes P450, lipoxygenase, and hydroperoxides. Cancer Res 55:5566–5573
24. 24. SS Hecht TE Spratt N Trushin 1997 Absolute configuration of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol formed metabolically from 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone Carcinogenesis 18 1851 1854 9328186 10.1093/carcin/18.9.1851 1:CAS:528:DyaK2sXmsFCju74%3D Hecht SS, Spratt TE, Trushin N (1997) Absolute configuration of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol formed metabolically from 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Carcinogenesis 18:1851–1854
25. 25. SS Hecht TE Spratt N Trushin 2000 Corrigendum: Absolute configuration of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol formed metabolically from 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone Carcinogenesis 20 850 Hecht SS, Spratt TE, Trushin N (2000) Corrigendum: Absolute configuration of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol formed metabolically from 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Carcinogenesis 20:850
26. 26. E Maser 1998 11β-Hydroxysteroid dehydrogenase responsible for carbonyl reduction of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in mouse lung microsomes Cancer Res 58 2996 2303 9679962 1:CAS:528:DyaK1cXkvVCnu70%3D Maser E (1998) 11β-Hydroxysteroid dehydrogenase responsible for carbonyl reduction of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in mouse lung microsomes. Cancer Res 58:2996–2303
27. 27. CL Zimmerman Z Wu P Upadhyaya SS Hecht 2004 Stereoselective metabolism and tissue retention in rats of the individual enantiomers of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL), metabolites of the tobacco-specific nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) Carcinogenesis 25 1237 1242 14988218 10.1093/carcin/bgh120 1:CAS:528:DC%2BD2cXltVWmsbg%3D Zimmerman CL, Wu Z, Upadhyaya P, Hecht SS (2004) Stereoselective metabolism and tissue retention in rats of the individual enantiomers of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL), metabolites of the tobacco-specific nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK). Carcinogenesis 25:1237–1242
28. 28. YB Lao NX Yu F Kassie PW Villalta SS Hecht 2007 Formation and accumulation of pyridyloxobutyl DNA adducts in F344 rats chronically treated with 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and enantiomers of its metabolite, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol Chemical Res Toxicol 20 235 245 10.1021/tx060207r 1:CAS:528:DC%2BD2sXhs12guw%3D%3D Lao YB, Yu NX, Kassie F, Villalta PW, Hecht SS (2007) Formation and accumulation of pyridyloxobutyl DNA adducts in F344 rats chronically treated with 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and enantiomers of its metabolite, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol. Chem Res Toxicol 20:235–245
29. 29. M Soldan G Nagel M Losekam M Ernst E Maser 1999 Interindividual variability in the expression and NNK carbonyl reductase activity of 11β-hydroxysteroid dehydrogenase 1 in human lung Cancer Lett 145 49 56 10530769 10.1016/S0304-3835(99)00216-5 1:CAS:528:DyaK1MXlvVWltbY%3D Soldan M, Nagel G, Losekam M, Ernst M, Maser E (1999) Interindividual variability in the expression and NNK carbonyl reductase activity of 11β-hydroxysteroid dehydrogenase 1 in human lung. Cancer Lett 145:49–56
30. 30. KE Anderson GJ Hammons FF Kadlubar JD Potter KR Kaderlik KF Ilett RF Minchin CH Teitel HC Chou MV Martin FP Guengerich GW Barone NP Lang LA Peterson 1997 Metabolic activation of aromatic amines by human pancreas Carcinogenesis 18 1085 1092 9163700 10.1093/carcin/18.5.1085 1:CAS:528:DyaK2sXjtlKjtbw%3D Anderson KE, Hammons GJ, Kadlubar FF, Potter JD, Kaderlik KR, Ilett KF, Minchin RF, Teitel CH, Chou HC, Martin MV, Guengerich FP, Barone GW, Lang NP, Peterson LA (1997) Metabolic activation of aromatic amines by human pancreas. Carcinogenesis 18:1085–1092
31. 31. B Prokopczyk G Leder N Trushin AJ Cunningham S Akerkar B Pittman M Ramadani J Straeter HG Beger D Henne-Bruns K El-Bayoumy 2005 4-Hydroxy-1-(3-pyridyl)-1-butanone, an indicator for 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced DNA damage, is not detected in human pancreatic tissue Cancer Epidemiol Biomark Prev 14 540 541 10.1158/1055-9965.EPI-04-0626 1:CAS:528:DC%2BD2MXhs1Ghsbo%3D Prokopczyk B, Leder G, Trushin N, Cunningham AJ, Akerkar S, Pittman B, Ramadani M, Straeter J, Beger HG, Henne-Bruns D, El-Bayoumy K (2005) 4-Hydroxy-1-(3-pyridyl)-1-butanone, an indicator for 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced DNA damage, is not detected in human pancreatic tissue. Cancer Epidemiol Biomark Prev 14:540–541